Beta-Adrenergic Blockade Therapy for Autonomic Dysfunction is Less Effective for Elderly Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction

Overview

Journal Jpn Clin Med

Publisher Sage Publications

Specialty General Medicine

Date 2015 Oct 21

PMID 26483614

Authors

Ken Shimamoto

Masatoshi Kawana

Affiliations

Soon will be listed here.

Abstract

Objective: Heart rate variability (HRV) has been reported to be an independent predictor of all-cause and sudden cardiac death in patients with heart failure. In the aging heart, however, both autonomic and cardiac functions appear to be altered. We assessed the relationship between aging and responsiveness of HRV and ventricular remodeling to beta-adrenergic blockade therapy in patients with heart failure and reduced ejection fraction (HFREF).

Methods: Twenty-eight clinically stable patients with chronic heart failure, sinus rhythm, and left ventricular ejection fraction <50% as confirmed by echocardiography were included. At baseline and after carvedilol treatment, 24-hour ambulatory Holter monitor recording was used to analyze HRV indices by the maximum entropy method. Changes in these parameters were compared among three age groups.

Results: HR decreased in all groups after carvedilol treatment, but was still highest in the youngest group despite the same treatment doses. Time and frequency domain variables improved. The response of time domain variables (the standard deviation of all normal sinus to normal sinus [NN] intervals and the standard deviation of the averages of NN intervals in all 5-minute or 30-minute segments) to carvedilol therapy significantly decreased with increasing age. Ventricular reverse remodeling induced by carvedilol therapy significantly decreased with increasing age. Increases in time domain variables and a low-frequency domain moderately correlated with left ventricular reverse remodeling.

Conclusion: Beta-adrenergic blockade therapy improved HRV variables and ventricular remodeling in HFREF patients; however, the response tended to be milder in the elderly. HRV improvement was associated with ventricular reverse remodeling.

References

Challapalli S, KADISH A, Horvath G, Goldberger J . Differential effects of parasympathetic blockade and parasympathetic withdrawal on heart rate variability. J Cardiovasc Electrophysiol. 1999; 10(9):1192-9. DOI: 10.1111/j.1540-8167.1999.tb00295.x. View

. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17(3):354-81. View

Oberhauser V, Schwertfeger E, Rutz T, Beyersdorf F, Rump L . Acetylcholine release in human heart atrium: influence of muscarinic autoreceptors, diabetes, and age. Circulation. 2001; 103(12):1638-43. DOI: 10.1161/01.cir.103.12.1638. View

Paintal A . VAGAL AFFERENT FIBRES. Ergeb Physiol. 1963; 52:74-156. View

Rahman F, Pechnik S, Gross D, Sewell L, Goldstein D . Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Clin Auton Res. 2011; 21(3):133-41. PMC: 3094491. DOI: 10.1007/s10286-010-0098-y. View

Shih H, Lee B, Lee R, Boyle A . The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol. 2010; 57(1):9-17. PMC: 3031493. DOI: 10.1016/j.jacc.2010.08.623. View

Brodde O, Leineweber K . Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur J Pharmacol. 2004; 500(1-3):167-76. DOI: 10.1016/j.ejphar.2004.07.022. View

Schwartz P, De Ferrari G . Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev. 2010; 16(2):101-7. DOI: 10.1007/s10741-010-9179-1. View

Jugdutt B . Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010; 15(5):401-5. DOI: 10.1007/s10741-010-9164-8. View

10.

Leineweber K, Klapproth S, Beilfuss A, Silber R, Heusch G, Philipp T . Unchanged G-protein-coupled receptor kinase activity in the aging human heart. J Am Coll Cardiol. 2003; 42(8):1487-92. DOI: 10.1016/s0735-1097(03)01063-5. View

11.

Bullinga J, Alharethi R, Schram M, Bristow M, Gilbert E . Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005; 11(9):693-9. DOI: 10.1016/j.cardfail.2005.06.435. View

12.

Remme W, Riegger G, Hildebrandt P, Komajda M, Jaarsma W, Bobbio M . The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther. 2004; 18(1):57-66. DOI: 10.1023/B:CARD.0000025756.32499.6f. View

13.

Xiao R, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta E . Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci. 2006; 27(6):330-7. DOI: 10.1016/j.tips.2006.04.009. View

14.

Chiu K, Chan H, Chu S, Lin T . Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure. Auton Neurosci. 2006; 132(1-2):76-80. DOI: 10.1016/j.autneu.2006.10.008. View

15.

Kleiger R, Stein P, Bigger Jr J . Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005; 10(1):88-101. PMC: 6932537. DOI: 10.1111/j.1542-474X.2005.10101.x. View

16.

Zulfiqar U, Jurivich D, Gao W, Singer D . Relation of high heart rate variability to healthy longevity. Am J Cardiol. 2010; 105(8):1181-5. DOI: 10.1016/j.amjcard.2009.12.022. View

17.

Kaye D, Esler M . Autonomic control of the aging heart. Neuromolecular Med. 2008; 10(3):179-86. DOI: 10.1007/s12017-008-8034-1. View

18.

Nadal-Ginard B, Kajstura J, Leri A, Anversa P . Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003; 92(2):139-50. DOI: 10.1161/01.res.0000053618.86362.df. View

19.

Malliani A, Recordati G, Schwartz P . Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J Physiol. 1973; 229(2):457-69. PMC: 1350316. DOI: 10.1113/jphysiol.1973.sp010147. View

20.

Liu H, Zhao R, Zhi J, Wu B, Fu M . Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity. 1999; 29(1):43-51. DOI: 10.3109/08916939908995971. View